Cerebrospinal Fluid (CSF) Management Market Size, Share, Global Industry Trends, Growth, Opportunities, Emerging Demand and Forecast 2022-2031

“The cerebrospinal fluid (CSF) management market is projected to grow at a CAGR of 4.4%.”
The global cerebrospinal fluid (CSF) management market is projected to reach USD 1.56 billion by 2022 from an estimated USD 1.26 billion in 2017, at a CAGR of 4.4%. The high prevalence of hydrocephalus and the subsequent increase in the number of shunting procedures and the growing geriatric population are factors driving the growth of this market. The growing healthcare market in developing economies is also expected to provide growth opportunities for players in the market. However, the dearth of trained professionals and complications related to CSF shunts may challenge market growth during the forecast period to a certain extent.

“By product, the shunts segment is expected to grow at the highest CAGR during the forecast period (2022–2031).”
The market is segmented by product into shunts and external drainage systems. The shunts segment is expected to grow at highest CAGR during the forecast period. This can be attributed to growing number of shunting procedures performed worldwide as well as the increasing number of revision shunt surgeries being performed due to shunt malfunction and infection.

“By end user, the pediatric segment is expected to be the fastest growing segment during the forecast period.”
Based on end user, the global cerebrospinal fluid (CSF) management market is segmented into pediatric, adult, and geriatric end users. The pediatric segment is expected to grow at the highest CAGR during the forecast period and this growth is attributed to the high prevalence of congenital hydrocephalus along with the rising number of shunting procedures performed in the pediatric population.

Request Sample For More Insights : https://www.sdki.us/sample-request-109775

“Asia Pacific to witness the highest growth during the forecast period”
Asia Pacific is expected to grow at the highest CAGR during the study period. The highest growth rate of the Asia Pacific market can be primarily attributed to high prevalence of congenital hydrocephalus in China, growing geriatric population in Japan, and increasing medical tourism in India and several RoAPAC countries.

Break of primary participants was as mentioned below:
• By Company Type – Tier 1–65%, Tier 2–25% and Tier 3–10%
• By Designation – C-level–30%, Director Level–48%, Others–22%
• By Region – North America–48%, Europe–20%, Asia Pacific–25%, Row–7%

The key players in the global cerebrospinal fluid (CSF) management market are Medtronic (Ireland), Integra (US), B. Braun (Germany), DePuy Synthes (US), Spiegelberg GmbH & Co. KG (Germany), SOPHYSA (France), Natus Medical (US), Dispomedica GmbH (Germany), Delta Surgical Limited (UK), Argi Grup (Turkey), Moller Medical GmbH (Germany), G. SURGIWEAR LTD. (India), and Wellong Instruments Co., Ltd. (Taiwan).

Access Free PDF With Graphs and Charts : https://www.sdki.us/sample-request-109775

Research Coverage:
The report analyzes the cerebrospinal fluid (CSF) management market and aims at estimating the market size and future growth potential of this market based on various segments such as product, end user, and region. The report also includes the competitive analysis of key players in this market along with their company profiles, product and service offerings, recent developments, and key market strategies.

Related Reports:-

Cerebrospinal Fluid (CSF) Management Market
Magnetic Resonance Imaging (MRI) Systems Market
Airway Management Devices Market
Occlusion Devices Market

Leave a Reply

Your email address will not be published.